BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1653 related articles for article (PubMed ID: 15746883)

  • 1. Clinical trial design, nasal allergen challenge models, and considerations of relevance to pediatrics, nasal polyposis, and different classes of medication.
    Akerlund A; Andersson M; Leflein J; Lildholdt T; Mygind N
    J Allergy Clin Immunol; 2005 Mar; 115(3 Suppl 1):S460-82. PubMed ID: 15746883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes and adverse effect monitoring in allergic rhinitis.
    Juniper EF; Ståhl E; Doty RL; Simons FE; Allen DB; Howarth PH
    J Allergy Clin Immunol; 2005 Mar; 115(3 Suppl 1):S390-413. PubMed ID: 15746880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental models for the evaluation of treatment of allergic rhinitis.
    Day JH; Ellis AK; Rafeiro E; Ratz JD; Briscoe MP
    Ann Allergy Asthma Immunol; 2006 Feb; 96(2):263-77; quiz 277-8, 315. PubMed ID: 16498847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of sublingual specific immunotherapy in intermittent and persistent allergic rhinitis in children: an observational case-control study on 171 patients. The EFESO-children multicenter trial.
    Acquistapace F; Agostinis F; Castella V; Kantar A; Novembre E; Perrone MR; Pietrasanta M; Sambugaro R; Milani M
    Pediatr Allergy Immunol; 2009 Nov; 20(7):660-4. PubMed ID: 19320852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diminished response to grass pollen allergen challenge in subjects with concurrent house dust mite allergy.
    Reinartz SM; van Ree R; Versteeg SA; Zuidmeer L; van Drunen CM; Fokkens WJ
    Rhinology; 2009 Jun; 47(2):192-8. PubMed ID: 19593978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy and pharmacokinetic profiles of intranasal and oral cetirizine in a repeated allergen challenge model of allergic rhinitis.
    Korsgren M; Andersson M; Borgå O; Larsson L; Aldén-Raboisson M; Malmqvist U; Greiff L
    Ann Allergy Asthma Immunol; 2007 Apr; 98(4):316-21. PubMed ID: 17458426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preventive immunotherapy].
    Boquete M; Carballada F; Expósito F; González A
    Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages.
    Gosset P; Tillie-Leblond I; Malaquin F; Durieu J; Wallaert B; Tonnel AB
    Clin Exp Allergy; 1997 Apr; 27(4):379-88. PubMed ID: 9146930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: effects of single allergen challenge.
    Holm A; Dijkstra M; Kleinjan A; Severijnen LA; Boks S; Mulder P; Fokkens W
    J Allergy Clin Immunol; 2001 Apr; 107(4):627-33. PubMed ID: 11295650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rhinitis in adults].
    Kalogjera L
    Acta Med Croatica; 2011; 65(2):181-7. PubMed ID: 22359885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishing a model of seasonal allergic rhinitis and demonstrating dose-response to a topical glucocorticosteroid.
    Ahlström-Emanuelsson C; Persson CG; Svensson C; Andersson M; Hosszu Z; Akerlund A; Greiff L
    Ann Allergy Asthma Immunol; 2002 Aug; 89(2):159-65. PubMed ID: 12197572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement.
    Bousquet J; Schünemann HJ; Bousquet PJ; Bachert C; Canonica GW; Casale TB; Demoly P; Durham S; Carlsen KH; Malling HJ; Passalacqua G; Simons FE; Anto J; Baena-Cagnani CE; Bergmann KC; Bieber T; Briggs AH; Brozek J; Calderon MA; Dahl R; Devillier P; Gerth van Wijk R; Howarth P; Larenas D; Papadopoulos NG; Schmid-Grendelmeier P; Zuberbier T
    Allergy; 2011 Jun; 66(6):765-74. PubMed ID: 21496059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bet v 1-specific IgA increases during the pollen season but not after a single allergen challenge in children with birch pollen-induced intermittent allergic rhinitis.
    Keen C; Johansson S; Reinholdt J; Benson M; Wennergren G
    Pediatr Allergy Immunol; 2005 May; 16(3):209-16. PubMed ID: 15853949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of loteprednol etabonate nasal spray suspension on seasonal allergic rhinitis assessed by allergen challenge in an environmental exposure unit.
    Krug N; Hohlfeld JM; Geldmacher H; Larbig M; Heermann R; Lavallee N; Nguyen DT; Petzold U; Hermann R
    Allergy; 2005 Mar; 60(3):354-9. PubMed ID: 15679722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting adenosine receptors in the treatment of allergic rhinitis: a randomized, double-blind, placebo-controlled study.
    Rimmer J; Peake HL; Santos CM; Lean M; Bardin P; Robson R; Haumann B; Loehrer F; Handel ML
    Clin Exp Allergy; 2007 Jan; 37(1):8-14. PubMed ID: 17210036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of lumiward immunoassay system for detection of specific IgE associated with allergic rhinitis.
    Yamada K; Ohashi Y; Tanaka A; Kakinoki Y; Washio Y; Hayashi M; Kishimoto K; Nakai Y
    Acta Otolaryngol Suppl; 1998; 538():169-77. PubMed ID: 9879417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasal treatment with a microemulsion reduces allergen challenge-induced symptoms and signs of allergic rhinitis.
    Andersson M; Greiff L; Wollmer P
    Acta Otolaryngol; 2008 Jun; 128(6):666-9. PubMed ID: 18568502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproducibility of nasal allergen challenge in evaluating the efficacy of intranasal corticosteroid treatment.
    Proud D; Riker DK; Togias A
    Clin Exp Allergy; 2010 May; 40(5):738-44. PubMed ID: 20337650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do the leukotriene receptor antagonists work in children with grass pollen-induced allergic rhinitis?
    Keskin O; Alyamac E; Tuncer A; Dogan C; Adalioglu G; Sekerel BE
    Pediatr Allergy Immunol; 2006 Jun; 17(4):259-68. PubMed ID: 16771779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-dependent effects of budesonide aqueous nasal spray on symptoms in a daily nasal allergen challenge model.
    Andersson M; Svensson C; Persson C; Akerlund A; Greiff L
    Ann Allergy Asthma Immunol; 2000 Oct; 85(4):279-83. PubMed ID: 11061470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 83.